Akari Therapeutics, Plc (AKTX)

Akari Therapeutics, Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.2	2.6	3.85	13.25	9.36
Cash & Short-Term Investments	5.2	2.6	3.85	13.25	9.36
Cash Growth	100.19%	-32.41%	-70.98%	41.54%	-33.40%
Prepaid Expenses	0.19	0.09	0.3	0.47	2.17
Restricted Cash	0.06	0.06	-	-	-
Other Current Assets	0.01	0.2	0.2	0.1	0.09
Total Current Assets	5.46	2.95	4.34	13.82	11.63
Goodwill	8.43	8.43	-	-	-
Other Intangible Assets	34	39.18	0.01	0.02	0.02
Total Assets	47.89	50.56	4.36	13.83	11.65
Accounts Payable	8.77	12.41	1.67	0.95	1.79
Accrued Expenses	2.34	3.14	1.57	3.15	3.18
Short-Term Debt	0.75	3.26	-	-	-
Other Current Liabilities	0.49	1.11	1.35	7.95	1.12
Total Current Liabilities	12.35	19.91	4.58	12.04	6.09
Long-Term Deferred Tax Liabilities	6.95	8.04	-	-	-
Other Long-Term Liabilities	0.26	0.38	-	-	-
Total Liabilities	19.56	28.33	4.58	12.04	6.09
Common Stock	-	5.32	1.32	0.75	0.48
Additional Paid-In Capital	234.32	212.71	174.75	167.08	153.13
Retained Earnings	-264.55	-247.25	-227.46	-217.45	-199.71
Comprehensive Income & Other	58.56	51.46	51.15	51.42	51.65
Shareholders' Equity	28.33	22.23	-0.23	1.79	5.55
Total Liabilities & Equity	47.89	50.56	4.36	13.83	11.65
Total Debt	0.75	3.26	-	-	-
Net Cash (Debt)	4.45	-0.66	3.85	13.25	9.36
Net Cash Growth	-	-	-70.98%	41.54%	-33.40%
Net Cash Per Share	5.29	-2.21	31.42	169.78	174.48
Filing Date Shares Outstanding	1.14	0.72	0.2	0.13	0.07
Total Common Shares Outstanding	1.13	0.66	0.17	0.09	0.06
Working Capital	-6.89	-16.96	-0.24	1.77	5.53
Book Value Per Share	25.03	33.44	-1.38	19.25	93.36
Tangible Book Value	-14.1	-25.38	-0.24	1.77	5.53
Tangible Book Value Per Share	-12.46	-38.18	-1.47	19.06	92.97
Machinery	-	-	-	-	0.16

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q